地中海ダイエットと:横断的な研究に基づく脳卒中の媒介的な役割
Mingjing Zhou1,2, Xuyan Zhao3, Peinan Liu3
1Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277, Yanta West Road, Xi'an, 710061, Shaanxi, People's Republic of China.
European journal of medical research
|August 22, 2025
まとめ
地中海ダイエットにこだわる方が 発作リスクの低下と関連していた. このダイエットパターンは脳卒中を媒介する神経保護をもたらす可能性があります. さらなる研究が推奨されています.
科学分野:
- 神経学
- 栄養学
- エピデミオロジー
背景:
- は,すべての人口に影響を与える広範囲にわたる神経学的障害です.
- 地中海食は 抗炎症と抗酸化メカニズムを通して 神経保護効果を示しています
- 地中海ダイエットとの危険性との具体的な関連は,さらなる調査が必要である.
研究 の 目的:
- 地中海ダイエットとのリスクとの関連を調べる
- この関連に寄与する重要な食事成分を特定する.
- 食事との関係における脳卒中などの潜在的な仲介因子を調査する.
主な方法:
- 全国保健栄養調査 (NHANES) データベース (2013年−2018年) の14,259人の参加者の分析.
- 地中海ダイエットとの関連性を評価するための重み付けのロジスティック回帰
- ランダムな森林とメディエーションの分析で,重要な食事成分とメディエーション経路を特定します.
主要な成果:
- 地中海食への従順性の向上は,エピレプシーのリスクの有意な低下と相関していた (OR=0. 50,P=0. 033).
- 穀物は重要な食材として 登場しました
- 脳卒中が重要なメディエーター (6. 49%のメディエーション,P=0. 034) であり,地中海食と糖尿病の相互作用が観察された (P=0. 029).
結論:
- 地中海ダイエットに固執する人は 発作リスクが低くなります
- 脳卒中はこの保護的関連を媒介する可能性があります.
- 地中海ダイエットは の治療に有効な戦略であり 長期的研究が必要となります
関連する概念動画
01:24Epilepsy and Seizures: Overview
277
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
277
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:14Antiepileptic Drugs: Glutamate Antagonists
512
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
512
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
446
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
446